Kendle Realigns C-Suite Leadership to Drive Increased Innovation, Productivity and Organizational Efficiency
CINCINNATI, July 28 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL ), a leading, global full-service clinical research organization, today announced the realignment of its C-suite to strengthen its competitive position and position the Company for continued growth as a top-tier gl...
Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan
MUMBAI, July 24 /PRNewswire/ --
- Frost & Sullivan's Food & Beverage Focus 2009 Annual Executive
MindXchange on Biotechnology Applications in the Food & Beverage and Dietary
The Indian food processing industry has seen some spectacular product
Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply
- The CDC Reinstates Booster Dose of Hib Vaccine -
SWIFTWATER, Pa., June 25 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY ), announced today that the company has been able to increase the supply of its Hib-containing vaccines...
Microfluidics Expands Distributorship in Japan with Exclusive POWREX Partnership to Meet Increased Demand in Pharmaceutical, Biotechnology and Energy Industries
NEWTON, Mass., June 3 /PRNewswire-FirstCall/ -- Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation (OTC Bulletin Board: MFLU), and POWREX Corporation have entered into an exclusive distributorship agreement whereby POWREX will market, sell and service Microfluidize...
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Large Cardiovascular Outcomes Study To Be Initiated
Manufacturing Comparability Analysis Complete: Exenatide Once Weekly NDA Submission Remains On Track
SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., March 26 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN ), El...
Proximity Systems' LAN Based Electronic Lock Management System Offers Increased Security, Efficiency and Reporting Capability for Wall-Mounted WorkStations
HOUSTON, Feb. 16 /PRNewswire/ -- Proximity Systems will be announcing the availability of the LAN Based Electronic Lock Management System for use in its retractable, wall-mounted WorkStations at the 2009 HIMSS Conference & Exhibition. The new patent-pending locking system simplifies and stream...
DuPont Expects Increased Global Seed Corn Share, Continued Agriculture Earnings Growth
Strong Pipeline and Superior Distribution System Will Continue to Fuel Growth and Generate Cash
NEW YORK, Feb. 10 /PRNewswire-FirstCall/ -- DuPont Group (NYSE: DD ) Vice President James C. Borel said today he expects DuPont business Pioneer Hi-Bred to grow its global seed corn market share ...
deCODE Discovers First Genetic Variant Conferring Increased Risk of Essential Tremor
REYKJAVIK, Iceland, February 2 /PRNewswire-FirstCall/ --
Scientists from deCODE genetics (Nasdaq: DCGN ) today report the discovery
of the first variation in the sequence of the human genome ever shown to
risk of essential tremor. The single-letter variant (or SNP)
Amgen's Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
Full Year 2008 Revenue Increased
2 Percent to $15.0 Billion; Fourth Quarter 2008 Revenue Flat at $3.75 Billion
Full Year 2008 GAAP Earnings Per Share Increased
38 Percent to $3.90; Fourth Quarter 2008 GAAP Earnings Per Share Increased
20 Percent to $0.91
2009 Total Revenue Expected to be...
The Medicare Hospital-Acquired Conditions Initiative Will Spur Increased Patient Screening and Potentially Increased Antibiotic Use
Majority of Physicians are Most Concerned About Lack of Reimbursement for
Vascular Catheter-Associated Infections, According to a New Report from Decision Resources
WALTHAM, Mass., Nov. 3 /PRNewswire/ -- Decision Resources, one of the
world's leading research and adv...
CryoLife's Fully Diluted Earnings Per Share Increased 71 Percent to $0.12 in Third quarter of 2008 from $0.07 in Third quarter of 2007
21 percent in third quarter of 2008 versus third quarter of 2007
ATLANTA, Oct. 30 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY ),
a biomaterials, medical device and tissue processing company, announced
today that revenues for the third qu...
Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
Third Quarter 2008 Revenue Increased
7 Percent to $3.9 Billion
Third Quarter 2008 GAAP Earnings Per Share were $1.09, an Increase from Third Quarter 2007 GAAP Earnings Per Share of $0.18
Full Year Revenue Guidance Raised from $14.6 Billion - $14.9 Billion to ...
Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares.
ST. LOUIS, Oct. 21 /PRNewswire-FirstCall/ --
HIGHLIGHTS: 2008 Results (all percentage comparisons are to comparable periods in
-- Q3 2008 Sales Driven By Consistent Research Sales Gain: Q3 2008 sales increased
7.4% to $540.6 million. Currency added 3.1% to organic growth ...
BioLife Solutions Credit Facility Increased to $9 Million
Access to Additional Capital Will Enable Revenue Growth
BOTHELL, Wash., Oct. 21 /PRNewswire-FirstCall/ -- BioLife Solutions
Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of
proprietary hypothermic storage and cryopreservation media products for
cells, tissues, and o...
In-Room Computers and Wall-Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency; Improved Patient Care
Centerpoint Medical Center and Houston-based Proximity Systems WorkStations: one year later
HOUSTON, Oct. 13 /PRNewswire/ -- One year after installing 400
Proximity Systems Computer WorkStations, Centerpoint Medical Center offers
favorable reviews and cites reasons wh...
New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
PALO ALTO, Calif., Aug. 24 /PRNewswire-FirstCall/ -- Varian, Inc.
(NasdaqGS: VARI) introduced its new dual wavelength X-ray diffractometer
for the analysis of small molecules and proteins. The SuperNova(TM) is the
first dual wavelength diffraction system to use entirely high intensity
CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007
Company posts record quarterly revenues of $27.2 million
ATLANTA, July 31 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY ),
a biomaterials, medical device and tissue processing company, announced
today that revenues for the second quarter of 2008 increased
18 percent to
Number of Patients Treated with an Antibiotic for MRSA Within U.S. Acute Care Hospitals Increased 8 Percent from 2006 to 2007
However, the Average Number of Days of Inpatient Therapy per Patient
Treated with an Antibiotic for MRSA Decreased by 10 Percent, According to New Data Released by Arlington Medical Resources
MALVERN, Penn., June 25 /PRNewswire/ -- Arlington Medical Resources
(AMR), a provider of...
Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis
EXTON, Pa., June 5 /PRNewswire/ -- BioTrends Research Group, Inc.
released its third annual TreatmentTrends (TM): Psoriasis publication,
providing insight into the management of psoriasis. This report is based on
responses to an online survey completed by 102 US Dermatologists in April
Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc.
Amended Master Purchase Contract Provides for the Sale of Ready to Drink
Suite of Nutritional Supplements to Provider Services, Inc. to be Increased
Annually by $3.4M or 142%
BASKING RIDGE, N.J., June 5 /PRNewswire/ -- Millennium Biotechnologies
Inc., wholly owned subsidi...
Nephrologists and Non-Nephrologists Alike Report Increased Attention on Chronic Kidney Disease
EXTON, Pa., May 23 /PRNewswire/ -- BioTrends Research Group, Inc.
released a Special Report: "Referrals in Nephrology," providing insight
into the referral patterns and co-management of patients with Chronic
Kidney Disease (pre-dialysis) from the perspective of Nephrologists,
LifeStem International, Inc. Announces Increased Revenues, Decreased Operating Expenses
LAGUNA HILLS, Calif., May 14 /PRNewswire-FirstCall/ -- LifeStem
International, Inc., (OTC Bulletin Board: LSTM), formerly CalbaTech, Inc.,
an emerging life sciences company concentrating on providing products and
platforms to the research market for biotech and pharmaceutical companies
and to ...
APIC Statement on Need for Increased Prevention Measures for Healthcare-Associated Infections (HAIs)
WASHINGTON, Feb. 13 /PRNewswire-USNewswire/ -- The following statement
is attributable to Kathy Warye, CEO of the Association for Professionals in
Infection Control and Epidemiology (APIC):
"APIC is concerned with the increased
rate of antibiotic resistant
infections -- as high as 70 perce...
Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007
BEIJING and CLAREMONT, Calif., Jan. 30 /Xinhua-PRNewswire-FirstCall/ --
Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) reports
that the volume of bio-enhanced feed products sold during the fourth
quarter of 2007 strengthened over the third quarter of 2007 and increased
Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
PRINCETON, N.J., Oct. 31 /PRNewswire-FirstCall/ -- Novo Nordisk (NYSE:
NVO), a global healthcare company, today released its financial statement
for the period January 1, 2007 to September 30, 2007. -- Novo Nordisk increased
sales by 14% in local currencies and by 9% in Danish kroner due ...
10,000 New Jobs, Investments Increased
FRANKFURT, Germany, May 12 /PRNewswire/ --
- German Chemical Parks Record Growth - Attractive Business Model for
The number of employees in German chemical parks has increased
10,000 to 240,000 between 2006 and 2008. In this same period, the number of
Alfalight Gets $3.8M From DARPA - Funding has increased to $8.5 Million
MADISON, Wis. . The Defense Advanced Research Projects Agency (DARPA), has awarded Alfalight a $3.9 million grant for Research and Development under the DARPA Super High Efficiency Diode Source (SHEDS) program. There are options that could increase the funding to a total award of $5.3 million.
Wisconsin-based Third Wave reports increased revenue for 2003, fourth quarter
MADISON - Third Wave Technologies Inc. , a Madison-based provider of molecular diagnostics, reported fourth quarter and year-end earnings for 2003 last Tuesday. The year was transitional for Third Wave as the company focused its research, marketing and financial resources away from the genomic too...
VC funding increased in third quarter with shining life sciences
Last week, we reviewed the IPO market based on data from Burrill & Co.
By the way, Chicagoans will get not one but two chances to see and hear U.S. biotech guru Steve Burrill this coming week. He will be featured at the NanoCommerce event at McCormick Place in Chicago on Tuesday morning and he...
cMaster RTplusPCR System for increased sensitivity and product length
RT-PCR has become an essential method that allows researchers to determine
the presence, structure and level of expression of an mRNA transcript in
the organism, tissue or cell of interest. The basic protoc...
SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results
...279,571 for the same period in 2008. This decrease is primarily due to lower royalty income from our relationship with Perrigo.
Royalty income increased
34%, or $59,017 to $230,789 in the three months ended June 30, 2009, compared to $171,772 for the first quarter of 2009. This increase is a result of ...
Novavax Reports Second Quarter 2009 Financial Results
...rove to be safe and efficacious; Novavax's pilot plant facility is subject to extensive validation and FDA inspections, which may result in delays and increased
costs; the success of the Company's foreign joint venture and licensing agreements; the Company's ability to enter into future collaborations with ind...
American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
--2Q09 Revenue increased
20.7% YoY to $71.2 Million--
--2Q09 Net Incom...2009.
Revenue in the second quarter of 2009 increased
20.7% to $71.2 million
from $59.0 million in the s...al products. Revenue
from pharmaceutical products increased
17.4% to $58.4 million from $49.8
million in the p...
GenVec Reports Second Quarter 2009 Financial Results
... revenues associated with our FMD and malaria programs, partially offset by increased
revenue associated with our HIV program, as compared to the comparable prio... in revenue associated with our HIV program in each period is due mainly to increased
research and process development efforts as compared to the comparable prio...
SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
...es of $15.1 million for the second quarter of 2009 increased
from $10.6 million for the second quarter of 2008 as a result of increased
legal expenses, higher FAS123(R) expenses, higher ...o $57 million. The increase in burn rate is due to increased
legal expenses, and...
OncoGenex Reports Second Quarter 2009 Financial Results
...able to common shareholders for the second quarter increased
to $4.6 million from $2.9 million in 2008. For the... 2009 the loss attributable to common shareholders increased
to $7.0 million from $5.4 million in 2008.
Resea...ch and development expenses for the second quarter increased
to $3.6 million from $1.1 million in 2008. For the...
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
...009 as compared to the second quarter of 2008, and increased
by approximately 2% as compared to the first quart...royalty revenue derived from sales of TAXUS stents increased
by 7.9%. The second quarter of 2009 represented th... which is designed to enable thinner stent struts, increased
flexibility and a lower stent profile while improv...
Repligen Reports First Quarter Fiscal Year 2010 Financial Results
...This increase in operating expenses of $787,000 was primarily the result of increased
spending associated with advancement of both our Phase 3 clinical trial of ...nd our Phase 2b clinical trial of RG2417 for bipolar depression, as well as increased
research and development expenses associated with our preclinical HDAC inhi...
The Breast Cancer Therapeutics Market in Australia
.../ -- Rising public awareness of breast cancer and available treatments have increased
revenues in the breast cancer therapeutics market in Australia. As the most...on developing targeted breast cancer therapies that offer patients not only increased
efficacy, but reduced side effects as well," explains Carole Gaffud, Frost ...
PDI Reports 2009 Second Quarter Financial Results
...ear ago period. These declines are primarily due to lower revenue. The overall increase in second quarter 2009 gross profit margin was attributable to increased
gross profit in the Product Commercialization Services segment. This segment recognized a negative gross profit of $5.0 million in 2008 related to the...